Moderna, Inc. (MRNA)
138.82
-6.31
(-4.35%)
USD |
NASDAQ |
Aug 24, 16:00
139.00
+0.18
(+0.13%)
After-Hours: 20:00
Moderna Total Assets (Quarterly) : 10.96B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.96B |
| March 31, 2026 | 11.49B |
| December 31, 2025 | 12.34B |
| September 30, 2025 | 12.14B |
| June 30, 2025 | 12.01B |
| March 31, 2025 | 12.70B |
| December 31, 2024 | 14.14B |
| September 30, 2024 | 15.80B |
| June 30, 2024 | 15.68B |
| March 31, 2024 | 16.73B |
| December 31, 2023 | 18.43B |
| September 30, 2023 | 19.45B |
| June 30, 2023 | 21.88B |
| March 31, 2023 | 24.12B |
| December 31, 2022 | 26.09B |
| September 30, 2022 | 26.06B |
| June 30, 2022 | 26.04B |
| March 31, 2022 | 27.61B |
| Date | Value |
|---|---|
| December 31, 2021 | 24.87B |
| September 30, 2021 | 20.92B |
| June 30, 2021 | 16.15B |
| March 31, 2021 | 12.69B |
| December 31, 2020 | 7.337B |
| September 30, 2020 | 4.651B |
| June 30, 2020 | 3.486B |
| March 31, 2020 | 2.068B |
| December 31, 2019 | 1.589B |
| September 30, 2019 | 1.591B |
| June 30, 2019 | 1.685B |
| March 31, 2019 | 1.806B |
| December 31, 2018 | 1.962B |
| September 30, 2018 | 1.489B |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 1.084B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioNTech SE | 23.26B |
| Kailera Therapeutics, Inc. | 1.211B |
| Sarepta Therapeutics, Inc. | 3.189B |
| Replimune Group, Inc. | 252.45M |
| Intellia Therapeutics, Inc. | 857.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.20B |
| Shareholders Equity (Quarterly) | 6.761B |
| Debt to Equity Ratio | 0.1904 |
| Current Ratio | 2.295 |
| Net Debt Paydown Yield | -0.39% |